Drug recalls, 2026-W29

FDA drug recalls, July 13 to 19, 2026

FDA posted 14 drug recalls the week of July 13, 2026: 14 Class II. Gasco Industrial Corp. has the most, with 6.

License: openFDA publishes this file under CC0 1.0.

FDA sorts recalls by risk. Class I: using the product could cause serious health problems or death. Class II: it could cause temporary or reversible health problems. Class III: it is unlikely to cause health problems.

For pharmacies and practices

Get this every Monday

Rivvi pulls the FDA drug recalls posted in the last 7 days and sends you the list each Monday morning. Add the drugs you stock or prescribe and it flags any that match.

Watch recalls in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams, with the weekly watch turned on.

Recalls posted July 13 to 19, 2026

Class II · Posted July 15, 2026 · Started June 24, 2026 · Ongoing

Azacitidine for Injection 100mg/Vial

Product
Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01
Firm
Reliance Life Sciences Private Limited, Navi Mumbai, India
Reason
Lack of Sterility Assurance
Lots
Lot, expiry: RAZM0425A Jun 30, 2027; RAZM0525A Jun 30, 2027; RAZM0725A Jun 30, 2027; RAZM0825A Jun 30, 2027; RAZM0925A Jul 31, 2027; RAZM1125A Jul 31, 2027; RAZM1225A Jul 31, 2027; RAZM1425A Jul 31, 2027; RAZM1525A Jul 31, 2027; RAZM1625A Aug 31, 2027; RAZM1725A Aug 31, 2027; RAZM2025A Sep 30, 2027
Quantity
8,001 vials
Distribution
Nationwide in the USA
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0674-2026

Class II · Posted July 15, 2026 · Started June 24, 2026 · Ongoing

Bortezomib for Injection 3.5mg/Vial

Product
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Firm
Reliance Life Sciences Private Limited, Navi Mumbai, India
Reason
Lack of Sterility Assurance
Lots
Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
Quantity
11,400 vials
Distribution
Nationwide in the USA
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0673-2026

Class II · Posted July 15, 2026 · Started June 24, 2026 · Ongoing

Pemetrexed for Injection 500mg/Vial

Product
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Firm
Reliance Life Sciences Private Limited, Navi Mumbai, India
Reason
Lack of Sterility Assurance
Lots
Lot, expiry: RPTH0125A Jan 31, 2028; RPTH0225A Jan 31, 2028; RPTH0325A Jan 31, 2028; RPTH0725A Apr 30, 2028;
Quantity
5,020 vials
Distribution
Nationwide in the USA
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0672-2026

Class II · Posted July 15, 2026 · Started June 24, 2026 · Ongoing

Pemetrexed for Injection 100mg/Vial

Product
Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
Firm
Reliance Life Sciences Private Limited, Navi Mumbai, India
Reason
Lack of Sterility Assurance
Lots
Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028
Quantity
12,000 vials
Distribution
Nationwide in the USA
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0671-2026

Class II · Posted July 15, 2026 · Started June 24, 2026 · Ongoing

Methohexital Sodium

Product
Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46.
Firm
QuVa Pharma, Inc., Sugar Land, TX
Reason
Failed Impurities/Degradation Specifications
Lots
Lot #: 10162261, 10162262, 10162279, 10162280, Exp. Date 07/21/2026; 10162314, 10162315, Exp. Date 07/22/2026; 10162465, 10162466, 10162491, 10162492, Exp. Date 07/26/2026; 10162542, 10162543, Exp. Date 07/27/2026; 10162559, 10162560, Exp. Date 07/28/2026; 10162623, 10162624, Exp. Date 07/29/2026; 10162693, 10162694, Exp. Date 07/30/2026; 10162735, 10162736, 10162753, 10162754, Exp. Date 07/31/2026; 10162772, 10162773, 10162791, 10162792, 10162810, 10162811, Exp. Date 08/02/2026; 10162820, Exp. Date 08/03/2026; 10162853, 10162854, Exp. Date 08/04/2026; 10163046, Exp. Date 08/09/2026…
Distribution
Nationwide within the United States
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0664-2026

Class II · Posted July 15, 2026 · Started June 11, 2026 · Ongoing

Medline Remedy Specialized Silicone Cream (Hydraguard-D ),Manufactured for Medline…

Product
Medline Remedy Specialized Silicone Cream (Hydraguard-D ),Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 80090 2 FL OZ (59 mL) NDC 53329-159-13 4 FL OZ (118 mL) NDC 53329-159-04
Firm
BioMed Laboratories, LLC., Dallas, TX
Reason
Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
Lots
Lots 0001882643, 0001887165, 0001888441, 0001900835, 0001931329 & 0001951664 May 2026 Lots 0001882644, 0001899186, 0001903516, 0001905970, 0001911902, 0001917707 & 0001920638 June 2026 Lot 0001927080 Oct 2026 Lots 0001937896, 0001952194 & 0001962232, Jan-2027 Lots 0001981964, 0001981965, 0001994680 & 002012768, May 2027 Lot 0001998027, Jun 2027 Lot 002012787, Aug 2027
Quantity
509,652 tubes
Distribution
Nationwide in the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0663-2026

Class II · Posted July 15, 2026 · Started June 7, 2026 · Ongoing

methohexital sodium

Product
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Firm
ONESOURCE SPECIALTY PHARMA LIMITED, Bengaluru, India
Reason
Failed Impurities/Degradation Specifications
Lots
Lot #: 7000612A, Exp. Date 1/2028
Quantity
4284 vials
Distribution
Nationwide within the United States
RxNorm
methohexital sodium (RxCUI 1244233)
Recall number
D-0662-2026

Class II · Posted July 15, 2026 · Started May 29, 2026 · Ongoing

Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%

Product
Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%, 32 oz., 946 mL, Distributed by: Drogueria San Juan, Calle De Diego 590, Sabana Llana Rio Piedras, PR 00924, UPC 659685696567.
Firm
Gasco Industrial Corp., Gurabo, PR
Reason
Subpotent drug
Lots
Lots 250206B1, 250218B2, 250507B1, within expiry
Distribution
Nationwide within the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0670-2026

Class II · Posted July 15, 2026 · Started May 29, 2026 · Ongoing

Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%

Product
Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%, 16 oz, 474 mL, Distributed by: Drogueria San Juan, Calle De Diego 590, Sabana LLana Rio Piedras, PR 00924, UPC 69685696529
Firm
Gasco Industrial Corp., Gurabo, PR
Reason
Subpotent drug
Lots
Lots 250109B1, 250110B1, 250228B1, 250303B1, 250304B1, 250305B1, 250306B1, 250306B2 within expiry
Distribution
Nationwide within the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0669-2026

Class II · Posted July 15, 2026 · Started May 29, 2026 · Ongoing

Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%

Product
Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%, 1 gallon (3.78 liter), Distributed by: Drogueria San Juan, Calle De Diego 590, Sabana LLana Rio Piedras, PR 00924
Firm
Gasco Industrial Corp., Gurabo, PR
Reason
Subpotent drug
Lots
Lots 250221A5, 250224A2 within expiry
Distribution
Nationwide within the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0668-2026

Class II · Posted July 15, 2026 · Started May 29, 2026 · Ongoing

Gasco Isopropyl Alcohol 70%

Product
Gasco Isopropyl Alcohol 70%, 32 oz (946 mL) Gasco Industrial Corp., PO Box 1360, Gurabo PR 00778, UPC 7 87302 12363 6.
Firm
Gasco Industrial Corp., Gurabo, PR
Reason
Subpotent drug
Lots
Lot 250218B3, within expiry
Distribution
Nationwide within the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0667-2026

Class II · Posted July 15, 2026 · Started May 29, 2026 · Ongoing

Gasco Isopropyl Alcohol 70%

Product
Gasco Isopropyl Alcohol 70%, Net Contents: 1 US Gallon (3.78 L), Manufactured by: Gasco Industrial Corp., PO Box 1360, Gurabo, PR 00778, Made in USA
Firm
Gasco Industrial Corp., Gurabo, PR
Reason
Subpotent drug
Lots
Lots 250108A2, 250109A1, 250115A1, 250124A1, 250213A1, 250220Z3, 250221A3, 250221A4, 250224A1, 250303A3, 250306A1, 250307A1, within expiry
Distribution
Nationwide within the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0666-2026

Class II · Posted July 15, 2026 · Started May 29, 2026 · Ongoing

Gasco Isopropyl Alcohol 70%

Product
Gasco Isopropyl Alcohol 70%, Net Contents: 16 Oz. (474 mL). Manufactured by: Gasco Industrial Corp., PO Box 1360 Gurabo PR 00778 Made in USA UPC 7 87302 13044 3
Firm
Gasco Industrial Corp., Gurabo, PR
Reason
Subpotent drug
Lots
Lot 250306B3, within expiry
Distribution
Nationwide within the US
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0665-2026

Class II · Posted July 15, 2026 · Started May 19, 2026 · Ongoing

Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9)

Product
Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01), b) 500 g (NDC 84849-000-02), (c) 100 g (NDC 84849-000-03), Rx Only, Shimoga Chemicals Address -W-57A, MIDC Kupwad Samgli, Maharashtra, 416436, India.
Firm
Shimoga Chemicals, Sangli, India
Reason
cGMP deviations
Lots
Lot #: a) CC/004/24-25, Exp Date September 2029; CC0032526, Exp. Date August 2030 b) CC0442526, Exp. Date Aug 2030; CC/005/24-25, Exp. Date November 2029 c) CC0032526, Exp. Date August 2030; CC/009/24-25, Exp. Date January 2030;CC/005/24-25, Exp. Date November 2029.
Distribution
CA & FL only
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0691-2026

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

About this data

Each row is one FDA drug enforcement report: one product from one firm. A week here is Monday to Sunday, keyed on the date FDA listed the recall in its weekly Enforcement Report. The date the firm started the recall is shown on each row and is often weeks earlier.

Class I means use of the product could cause serious health problems or death. Class II means it could cause temporary or reversible health problems. Class III means it is unlikely to cause health problems. RxNorm names and RxCUIs come from openFDA's match of the product to its drug label. Compounded products often have no match.

This page lists public records. It is not medical advice. Check the FDA record before acting on a recall.

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing